Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Lymphocytic Chronic B-Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04059081
What this trial is testing

A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment

Who this might be right for
Chronic Lymphocytic Leukemia
Deok-Hwan Yang 31
Early research (Phase 1)Not Yet RecruitingNCT07679919
What this trial is testing

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic LeukemiaHairy Cell Leukemia+1 more
Luminary Therapeutics 27
Not applicableUnknownNCT03469895
What this trial is testing

Autoimmune Cytopenia and BcR Inhibitors

Who this might be right for
Autoimmune Cytopenia Associated With Chronic Lymphocytic Leukemia
Institut Paoli-Calmettes 40
Early research (Phase 1)Study completedNCT00004057
What this trial is testing

Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT01532700
What this trial is testing

An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
University Health Network, Toronto 28
Early research (Phase 1)Study completedNCT01653717
What this trial is testing

CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Advanced CancersLeukemia
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03960840
What this trial is testing

Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaDiffuse Large B-cell Lymphoma+2 more
Novartis Pharmaceuticals 217
Early research (Phase 1)Active Not RecruitingNCT04732845
What this trial is testing

Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies

Who this might be right for
Non Hodgkin LymphomaAcute Lymphoblastic LeukemiaChronic Lymphocytic Leukemia
Benjamin Tomlinson 18
Testing effectiveness (Phase 2)Ended earlyNCT03125577
What this trial is testing

Combination CAR-T Cell Therapy Targeting Hematological Malignancies

Who this might be right for
B-cell Malignancies
Shenzhen Geno-Immune Medical Institute 100
Not applicableUnknownNCT03971565
What this trial is testing

Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Assistance Publique Hopitaux De Marseille 47
Post-approval studies (Phase 4)Active Not RecruitingNCT03229200
What this trial is testing

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

Who this might be right for
Lymphoma, B-CellLymphoma, Non-HodgkinLeukemia, B-cell+2 more
Pharmacyclics Switzerland GmbH 297
Testing effectiveness (Phase 2)UnknownNCT00628238
What this trial is testing

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic LeukemiaCLLUntreated+3 more
Chronic Lymphocytic Leukemia Research Consortium 80
Early research (Phase 1)Looking for participantsNCT05544019
What this trial is testing

Study of SGR-1505 in Mature B-Cell Neoplasms

Who this might be right for
Mature B-Cell NeoplasmNon Hodgkin LymphomaDLBCL+23 more
Schrödinger, Inc. 98
Early research (Phase 1)Study completedNCT01748721
What this trial is testing

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+43 more
Morphotek 27
Not applicableStudy completedNCT00060021
What this trial is testing

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

Who this might be right for
Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT00964821
What this trial is testing

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 459
Not applicableUnknownNCT03881592
What this trial is testing

Real-World Data Study Focused on Chronic Lymphocytic Leukemia (CLL) Patient Treatment Options and Their Effectiveness

Who this might be right for
Chronic Lymphocytic Leukemia
Brno University Hospital 400
Testing effectiveness (Phase 2)Study completedNCT00974233
What this trial is testing

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
University of Wisconsin, Madison 34
Testing effectiveness (Phase 2)Study completedNCT00007852
What this trial is testing

Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska 44
Testing effectiveness (Phase 2)Study completedNCT00462332
What this trial is testing

Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 86
Next Page